Clinical Trial

Quantitative Sensory Testing to Study Pain Perception in Autism

Study acronym: PPiA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 26, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims at assess sensory perception, and pain perception, in neurodivergent children and adolescent in the autism spectrum. To achieve this goal, the quantitive sensory testing (QST), a controlled and replicable protocol, will be used, to assess perception in different sensory modalities: heat sensations, mechanical detection threshold and pain threshold. As secondary aim, the cortical processing of thermal painful stimuli will be collected through electroencephalography (EEG) in order to investigate if there are differences in the cortical processing of painful stimuli between clinical sample and control sample, and if it could be associated with differences in the subjective experience between the two groups. Finally, it will be explored the association between such differences, and indexes of psychopathology and dispositional measures.
Trial Details
NCT Number NCT06659731
Lead Sponsor IRCCS Eugenio Medea
Conditions Autism Spectrum Disorder (ASD), Pain Perception
Enrollment 50 participants
Start Date 2024-07-17
Primary Completion 2025-07 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2024-10-26